Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122502958 | 12250295 | 8 | F | 20160325 | 20160722 | 20160408 | 20160728 | EXP | PHHO2016US005187 | SANDOZ | 68.57 | YR | F | Y | 85.71000 | KG | 20160728 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122502958 | 12250295 | 1 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 5 MG, DAILY FOR 28 DAYS | 85 | MG | 0 | 5 | MG | TABLET | QD | ||||
| 122502958 | 12250295 | 2 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 5 MG, DAILY FOR 28 DAYS | 85 | MG | 0 | 5 | MG | TABLET | |||||
| 122502958 | 12250295 | 3 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | UNK | 85 | MG | 0 | TABLET | |||||||
| 122502958 | 12250295 | 4 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 395 MG, Q28 DAYS | U | 76959 | 395 | MG | |||||||
| 122502958 | 12250295 | 5 | SS | DOXIL | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 61 MG, Q28 DAYS | N | 0 | 61 | MG | |||||||
| 122502958 | 12250295 | 6 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 150 UG, QD | U | 0 | 150 | UG | QD | ||||||
| 122502958 | 12250295 | 7 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | UNK | U | 0 | |||||||||
| 122502958 | 12250295 | 8 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 8 MG, PRN | U | 0 | 8 | MG | |||||||
| 122502958 | 12250295 | 9 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Oral | 600 MG, QD | U | 0 | 600 | MG | QD | ||||||
| 122502958 | 12250295 | 10 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 1000 U, QD | U | 0 | 1000 | DF | QD | ||||||
| 122502958 | 12250295 | 11 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Oral | 600 MG, QD | U | 0 | 600 | MG | QD | ||||||
| 122502958 | 12250295 | 12 | C | ATIVAN | LORAZEPAM | 1 | Oral | 2 MG, PRN | U | 0 | 2 | MG | |||||||
| 122502958 | 12250295 | 13 | C | INSULIN | INSULIN NOS | 1 | 0 | ||||||||||||
| 122502958 | 12250295 | 14 | C | COMPAZINE | PROCHLORPERAZINE MALEATE | 1 | Oral | 10 MG, PRN | U | 0 | 10 | MG | |||||||
| 122502958 | 12250295 | 15 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||
| 122502958 | 12250295 | 16 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, BID | U | 0 | 40 | MG | BID | ||||||
| 122502958 | 12250295 | 17 | C | QUINAPRIL. | QUINAPRIL | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 122502958 | 12250295 | 18 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | Oral | 2 MG, PRN | U | 0 | 2 | MG | |||||||
| 122502958 | 12250295 | 19 | C | HIDROCORTISON | HYDROCORTISONE | 1 | Unknown | U | 0 | ||||||||||
| 122502958 | 12250295 | 20 | C | CARAFATE | SUCRALFATE | 1 | Oral | 1 G, QID | 0 | 1 | G | QID | |||||||
| 122502958 | 12250295 | 21 | C | PROTONIX//PANTOPRAZOLE SODIUM SESQUIHYDRATE | 2 | Oral | 40 MG, BID | U | 0 | 40 | MG | BID | |||||||
| 122502958 | 12250295 | 22 | C | MARONIL | 2 | Oral | 2.5 MG, PRN | U | 0 | 2.5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122502958 | 12250295 | 1 | Malignant peritoneal neoplasm |
| 122502958 | 12250295 | 4 | Malignant peritoneal neoplasm |
| 122502958 | 12250295 | 5 | Malignant peritoneal neoplasm |
| 122502958 | 12250295 | 6 | Product used for unknown indication |
| 122502958 | 12250295 | 7 | Product used for unknown indication |
| 122502958 | 12250295 | 8 | Product used for unknown indication |
| 122502958 | 12250295 | 9 | Product used for unknown indication |
| 122502958 | 12250295 | 10 | Product used for unknown indication |
| 122502958 | 12250295 | 11 | Product used for unknown indication |
| 122502958 | 12250295 | 12 | Product used for unknown indication |
| 122502958 | 12250295 | 13 | Type 1 diabetes mellitus |
| 122502958 | 12250295 | 14 | Product used for unknown indication |
| 122502958 | 12250295 | 15 | Product used for unknown indication |
| 122502958 | 12250295 | 16 | Product used for unknown indication |
| 122502958 | 12250295 | 17 | Product used for unknown indication |
| 122502958 | 12250295 | 18 | Product used for unknown indication |
| 122502958 | 12250295 | 19 | Product used for unknown indication |
| 122502958 | 12250295 | 20 | Product used for unknown indication |
| 122502958 | 12250295 | 21 | Product used for unknown indication |
| 122502958 | 12250295 | 22 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122502958 | 12250295 | HO |
| 122502958 | 12250295 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122502958 | 12250295 | Acute kidney injury | |
| 122502958 | 12250295 | Hiatus hernia | |
| 122502958 | 12250295 | Nausea | |
| 122502958 | 12250295 | Septic shock | |
| 122502958 | 12250295 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122502958 | 12250295 | 1 | 20160210 | 20160226 | 0 | |
| 122502958 | 12250295 | 2 | 20160628 | 0 | ||
| 122502958 | 12250295 | 3 | 20160331 | 0 | ||
| 122502958 | 12250295 | 4 | 20160210 | 20160628 | 0 | |
| 122502958 | 12250295 | 5 | 20160210 | 20160628 | 0 |